Institutional Biosafety Committee (IBC)

The Institutional Biosafety Committee is a committee of the president that assures compliance for the biological safety aspects during the use of recombinant DNA, infectious agents (bacteria, fungi, parasites, viruses, and prions), mutagens and carcinogens, biological toxins, and biohazardous materials.

Committee

IBC Chair:  Angelo DeLucia, Ph.D., ext. 6135

Please submit all materials for IBC review to Trish Wilson, CRA, Regulatory Affairs Coordinator, Room F-239.

Meeting Dates

  • January 30, 2019 at 10 a.m. in NEW 2011
  • March 27, 2019 at 10 a.m. in NEW 2011
  • May 29, 2019 at 10 a.m. in NEW 2011
  • July 31, 2019 at 10 a.m. in NEW 2011
  • September 25, 2019 at 10 a.m. in NEW 2012
  • November 27, 2019 at 10 a.m. NEW 2011

 

All Biosafety Committee meetings are open to the public.

Contact

Trish Wilson, CRA
Regulatory Affairs Coordinator
Phone: 330.325.6364
Email: paw@neomed.edu

Institutional Biosafety Committee

Northeast Ohio Medical University